A canonical structure for the ligand-binding domain of nuclear receptors

The ability of nuclear receptors (NRs) to activate transcription of target genes requires the binding of cognate ligands to their ligand-binding domains (LBDs). Information provided by the three-dimensional structures of the unliganded RXR and the liganded RAR LBDs has been incorporated into a general alignment of the LBDs of all NRs. A twenty amino-acid region constitutes a NR-specif ic signature and contains most of the conserved residues that stabilize the core of the canonical fold of NR LBDs. A common ligand-binding pocket, involving predominantly hydrophobic residues, is inferred by homology modelling of the human RXR and glucocorticoid receptor ligand-binding sites according to the RAR holo-LBD structure. Mutant studies support these models, as well as a general mechanism for ligand-induced activation deduced from the comparison of the transcriptionally active RAR holo- and inactive RXR apo-LBD structures.

1. Gronemeyer, H. & Laudet, V., Nuclear Receptors. Protein Profile 2, (Academic Press, 1995), in the press.
2. Green, S. & Chambon, P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4, 309−314 (1988). | Article | PubMed | ISI | ChemPort |
3. Evans, R.M. The steroid and thyroid hormone receptor superfamily. Science 240, 889−895 (1988). | PubMed | ISI | ChemPort |
4. Gronemeyer, H. Transcription activation by estrogen and progesterone receptors. A. Rev. Genet. 25, 89−123 (1991). | Article | ISI | ChemPort |
5. Leid, M., Kastner, P. & Chambon, P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427−433 (1992). | Article | PubMed | ISI | ChemPort |
6. Chambon, P. The retinoid signalling pathway: molecular and genetic analysis. Semin. Cell Biol. 5, 115−125 (1994). | Article | PubMed | ChemPort |
7. Saatcioglu, F., Claret, F.X. & Karin, M. Negative transcriptional regulation by nuclear receptors. Sem. Cancer Biol. 5, 347−359 (1994). | ISI | ChemPort |
8. Dey, A., Minucci, S. & Ozato, K. Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo. Mol. cell. Biol. 14, 8191−8201 (1994). | PubMed | ISI | ChemPort |
9. Truss, M., Bartsch, J. & Beato, M. Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc. natn. Acad. Sci. U.S.A. 91, 11333−11337 (1994). | ChemPort |
10. Zenke, M., Munoz, A., Sap, J., Vennström, B. & Beug, H. V-erba oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61, 1035−1049 (1990). | Article | PubMed | ISI | ChemPort |
11. Danielian, P.S., White, R., Lees, J.A. & Parker, M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025−1033 (1992). | PubMed | ISI | ChemPort |
12. Barretino, D., Vivanco-Ruiz, M.d.M. & Stunnenberg, H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13, 3039−3049 (1994). | PubMed | ISI | ChemPort |
13. Durand, B. et al. Activation function 2 (AF-2) of RAR and RXR: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13, 5370−5382 (1994). | PubMed | ISI | ChemPort |
14. Leng, X. et al. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. cell. Biol. 15, 255−263 (1995). | PubMed | ISI | ChemPort |
15. Halachmi, S. et al. Oestrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455−1458 (1994). | PubMed | ISI | ChemPort |
16. Cavaillès, V., Dauvois, S., Danielian, P.S. & Parker, M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. natn. Acad. Sci. U.S.A. 91, 10009−10013 (1994). | ISI |
17. Cavaillès, V. et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741−3751 (1995). | PubMed | ISI | ChemPort |
18. LeDouarin, B. et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020−2033 (1995). | PubMed | ISI | ChemPort |
19. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A. & Moore, D.A. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374, 91−94 (1995). | Article | PubMed | ISI | ChemPort |
20. Vom Baur, E. et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. in the press.
21. Hörlein, A.J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397−403 (1995). | Article | PubMed | ISI | ChemPort |
22. Kurokawa, R. et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451−454 (1995). | Article | PubMed | ISI | ChemPort |
23. Chen, J.D. & Evans, R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454−457 (1995). | Article | PubMed | ISI | ChemPort |
24. Gronemeyer, H. & Moras, D. How to finger DNA. Nature 375, 190−191 (1995). | Article | PubMed | ISI | ChemPort |
25. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXRa. Nature 375, 377−382 (1995). | Article | PubMed | ISI | ChemPort |
26. Renaud, J.P. et al. D Crystal structure of the RARg ligand-binding domain bound to all-trans retinoic acid. Nature in the press.
27. Laudet, V., Hanni, C., Coll, J., Catzeflis, F. & Stehelin, D. Evolution of the nuclear receptor gene superfamily. EMBO J. 11, 1003−1013 (1992). | PubMed | ISI | ChemPort |
28. Koelle, M.R. et al. The Drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor superfamily. Cell 67, 59−77 (1991). | PubMed | ISI | ChemPort |
29. Program Manual for the Wisconsin Package, Version 8, September 1994, Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA 53711.
30. Lee, S. et al. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies. Molec. Endocrinol. 9, 826−837 (1995). | Article | ISI | ChemPort |
31. Benhamou, B. et al. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255, 206−209 (1992). | PubMed | ISI | ChemPort |
32. Sultan, C., Lumbroso, S., Poujol, N., Belon, C., Boudon, C. & Lobaccaro, J.M. Mutation of androgen receptor gene in androgen insensitivity syndromes. J. Steroid Biochem. molec. Biol. 46, 519−530 (1993). | Article | PubMed | ISI | ChemPort |
33. Carlstedt Duke, J. et al. Identification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other steroid hormone receptors. J. biol. Chem. 263, 6842−6848 (1988). | PubMed | ChemPort |
34. Strömstedt, P.E., Berkenstam, A., Jörnvall, H., Gustafsson, J.A. & Carlstedt-Duke, J. Radiosequence analysis of the human progestin receptor charged with [3H]promegestone. J. biol. Chem. 265, 12973−12977 (1990). | PubMed | ISI |
35. Yarbrough, W.G. et al. A single base insertion in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J. biol. Chem. 265, 8893−8900 (1990). | PubMed | ISI | ChemPort |
36. Weiss, R.E. & Refetoff, S. Thyroid hormone resistance. A. Rev. Med. 43, 363−375 (1992). | Article | ISI | ChemPort |
37. Byravan, S. et al. Two point mutations in the hormone binding domain of the mouse glucocorticoid receptor that dramatically reduce its function. Molec. Endocrinol. 5, 752−758 (1991). | ISI | ChemPort |
38. Veldscholte, J. et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173, 534−540 (1990). | PubMed | ISI | ChemPort |
39. Bhat, M.K., McPhie, P., Ting, Y.T., Zhu, X-G. & Cheng, S-Y. Structure of the carboxy-terminal region of thyroid hormone nuclear receptors and its possible role in hormone-dependent intermolecular interactions. Biochemistry 34, 10591−10599 (1995). | PubMed | ISI | ChemPort |
40. Ashraf, J. & Thompson, E.B. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two major phenotypes. Molec. Endocrinol. 7, 631−642 (1993). | Article | ISI | ChemPort |
41. Leid, M. Ligand-induced alteration of the protease sensitivity of retinoid X receptor alpha. biol. Chem. 269, 14175−14181 (1994). | ChemPort |
42. Thompson, J.D., Higgins, D.G. & Gibson, T.J. ClustalW: improving the sensitivity of progessive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673−4680 (1994). | PubMed | ISI | ChemPort |
43. Henikoff, S. & Henikoff, J.G. Amino acid substitution matrices from protein blocks. Proc. natn. Acad. Sci.U.S.A. 89, 10915−10919 (1992). | ChemPort |
44. Pierrat, B., Heery, D.M., Chambon, P. & Losson, R. A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast. Gene 143, 193−200 (1994). | Article | PubMed | ISI | ChemPort |
45. Milhon, J., Kohli, K. & Stallcup, M.R. Genetic analysis of the N-terminal end of the glucocorticoid receptor hormone binding domain. J. Steroid Biochem. molec. Biol. 51, 11−19, (1994). | Article | PubMed | ISI | ChemPort |
46. Vriend, G.A molecular modelling and drug design program. J. molec. Graph. 8, 52−56 (1990). | Article | ISI | ChemPort |
47. Rohrer, D.C. & Duax, W.L. 9a-Fluoro-16a-Methyl-11b,17a,21-Trihydroxy-1,4-pregnadiene-3,20-dione[Dexamethasone](C22H29FO5). Cryst. struct. Commun. 6, 123−126 (1977). | ChemPort |
48. Zechel, C., Shen, X.Q., Chambon, P. & Gronemeyer, H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimersto DR5 and DR4 elements. EMBO J. 13, 1414−1424 (1994). | PubMed | ISI | ChemPort |
49. Bourguet, W. et al. Purification, functional characterization, and crystallization of ligand-binding domain of the retinoid X receptor. Protein Expr. Pur. 6, 604−608 (1995) | Article | ISI | ChemPort |
50. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plot plots of protein structures. J. appl. Crystallogr. 24, 946−950 (1991). | Article | ISI |
51. Merritt, E.A. & Murphy, M.E.P Raster3D version 2.0, a program for photorealistic molecular graphics. Acta Crystollagr. D50, 869−873 (1994). | ChemPort |

	Top

	Top